Digitisation | November 11, 2025
Nitinotes secures CE mark for automated suturing platform ‘EndoZip’
Enabling a new era in minimally invasive obesity treatment across Europe
Enabling a new era in minimally invasive obesity treatment across Europe
Poviztra is a second brand of Wegovy
Acquisition expands Novo Nordisk’s leadership in obesity-related comorbidities and metabolic diseases
Wegovy achieved significant weight loss with one in three study participants losing 20% or more body weight
The survey revealed that the proportion of individuals experiencing constant thoughts about food throughout the day declined by 46 percent after starting Wegovy
The study showed a significant 29% reduction in the risk for heart attack, stroke and death from any cause in the Wegovy users
The accelerated approval is supported by results from part 1 of the ESSENCE trial
The randomized, double-blind, placebo-controlled Phase 1 study is designed to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of BGE-102 in healthy participants
The submission is based on data from the STEP UP and STEP UP T2D clinical trials
This approval marks a significant milestone in OneSource’s ongoing commitment to quality and regulatory compliance
Subscribe To Our Newsletter & Stay Updated
